Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network
Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network
复制标题
DOI：
10.1016/j.jsat.2004.03.012
复制
发表时间：
2004-07-01
影响因子：
3.9
通讯作者：
Blaine, J
中科院分区：
文献类型：
--
作者：
Forman, RF;Svikis, D;Blaine, J
已经开发了几种诊断物质使用障碍（SUD）的工具，但迄今为止，还没有一种工具成为社区临床研究的标准。为了选择最适合临床试验的SUD诊断工具，国家药物滥用治疗临床试验网络（CTN）实施了一项程序，其中36所大学的成瘾研究人员和62个社区的成瘾治疗提供者评估并排名了五种广泛认可的诊断工具：(1)DSM-lV （SCID）结构化临床访谈中的SUD部分；(2)《国际综合诊断访谈》第2版（CIDI-2） SUD部分；(3) DSM-IV诊断性访谈表（DIS-IV）中的SUD部分；(4)诊断统计手册- iv核对表（DSM-IV核对表）；物质依赖严重程度量表（SDSS）。为了协助评价和排名过程，以表格和叙述形式列出了每种文书的主要特征。参与者将每种乐器从1（最喜欢）到5（最不喜欢）排序。综合平均得分最高的是SCID(2.24)，其次是CIDI-2（2.59）、DIS（2.94）、DSM（3.40）和SDSS（3.83）。在讨论了每种工具的实用和科学优缺点后，CTN指导委员会选择了CIDI-2。CIDI-2的选择使诊断数据的收集标准化，并为CTN的从业人员和临床研究人员提供了一个通用的诊断工具。对实践/研究合作和倡议的影响进行了探讨。(C) 2004爱思唯尔公司版权所有。
Several instruments for diagnosing substance use disorders (SUD) have been developed, but to date none has emerged as the standard for community-based clinical studies. To select the most suitable SUD diagnostic instrument for its clinical trials, the National Drug Abuse Treatment Clinical Trials Network (CTN) implemented a procedure in which 36 university-based addiction researchers and 62 community-based addiction treatment providers evaluated and ranked five widely recognized diagnostic instruments: (1) the SUD section of the Structured Clinical Interview for DSM-lV (SCID); (2) the SUD section of the Composite International Diagnostic Interview, 2nd ed. (CIDI-2); (3) the SUD section of the Diagnostic Interview Schedule for DSM-IV Diagnosis (DIS-IV); (4) the Diagnostic Statistical Manual-IV Checklist (DSM-IV Checklist); and (5) the Substance Dependence Severity Scale (SDSS). To assist the evaluation and ranking process, key characteristics of each instrument were presented in tabular and narrative formats. Participants ranked each instrument from I (most preferred) to 5 (least preferred). The SCID received the best overall mean score (2.24) followed by the CIDI-2 (2.59), DIS (2.94), DSM Checklist (3.40) and the SDSS (3.83). After discussing the pragmatic and scientific advantages and disadvantages of each instrument, the CTN Steering Committee selected the CIDI-2. The selection of the CIDI-2 standardizes the collection of diagnostic data and provides a common diagnostic tool for practitioners and clinical researchers in the CTN. Implications for practice/research collaboration and initiatives are explored. (C) 2004 Elsevier Inc. All rights reserved.